|
May 8
|
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
|
|
May 8
|
Exact Sciences Announces First-Quarter 2024 Results
|
|
May 7
|
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
|
|
May 1
|
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
|
|
May 1
|
Exact Sciences to Participate in May Investor Conference
|
|
Apr 24
|
Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Apr 24
|
Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)
|
|
Apr 22
|
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
|
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|
|
Apr 17
|
Why Exact Sciences (EXAS) Dipped More Than Broader Market Today
|
|
Apr 17
|
Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook
|
|
Apr 15
|
Exact Sciences names Aaron Bloomer CFO
|
|
Apr 15
|
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
|
|
Apr 12
|
Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1
|
|
Apr 11
|
Myriad Genetics (MYGN) Announces Favorable Research Results
|
|
Apr 11
|
Zacks Investment Ideas feature highlights: Exact Sciences, Kaiser Aluminum and Atmus Filtration Technologies
|
|
Apr 11
|
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
|
|
Apr 10
|
Exact Sciences (EXAS) Stock Moves -0.89%: What You Should Know
|
|
Apr 10
|
3 Buy-Rated Stocks Flexing Relative Strength
|
|
Apr 10
|
Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
|